2m 2m 2m 2m 2m 2m 2m
XERIS BIPH HLDG (XERS)
NASDAQ
$8.70-$0.005 (-0.06%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.6BMarket Cap
- 12.26%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
XERIS BIPH HLDG (XERS)
$8.70-$0.005 (-0.06%)
XERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.70 | ||
Change | +$0.10 (+1.16%) | ||
Open | $8.61 | ||
High | $8.81 | ||
Low | $8.54 | ||
Previous Close | $8.60 | ||
Volume | 1,562,899 | ||
30-Day Average Volume | 1,752,892 | ||
1-Week Change | 1.16% | ||
1-Month Change | -0.91% | ||
1-Year Change | 12.26% | ||
3-Year Change | 264.02% | ||
5-Year Change | 295.45% | ||
Fundamentals | |||
Shares Outstanding | 182.3M | ||
Total Assets | $411.9M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $91.0M | ||
Net Income | -$31.1M | ||
Free Cash Flow | $8.5M | ||
EBIT | -$31.1M | ||
EBITDA | -$28.4M | ||
Net Working Capital | $85.2M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -60 | ||
Enterprise Value/Revenue | 19 | ||
P/B | -163 | ||
P/E | -48 | ||
PEG | 0 | ||
Price/Free Cash Flow | 187 | ||
Price/Operating Cash Flow | 192 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue